RxDoctor Payments Data

Clinton Mallari, MD

Pain Medicine · Boise, IDNPI 1154345585

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 62.5% of it on its own, with 8 other manufacturers making up the rest. That places this record below the midpoint for pain medicine clinicians in ID, where the typical reported total is $4,838.

$1,458in general payments, 2019–2025

Across 93 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$911
  • Spinefrontier, Inc.$363
  • Medtronic$48
  • Pfizer$43
  • Tersera Therapeutics LLC$25
  • Biodelivery Sciences International, Inc.$21
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$1,458100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,458 in reported general payments places this provider in the 25th percentile of 32 pain medicine providers in Idaho.

See all pain medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$52,464
Medicare patients
90
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl67$270,969
Oxymorphone Hcl ErOxymorphone Hcl30$22,258
Oxycodone Hcl160$14,268
Fentanyl64$12,653
Hydromorphone Hcl118$10,963
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen202$10,410
Armodafinil35$3,654
Oxymorphone Hcl14$2,432
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen63$2,260
Testosterone Cypionate16$1,493
Gabapentin34$1,371
Carisoprodol55$1,127
Acetazolamide25$678
Pregabalin14$527
Hydroxychloroquine Sulfate15$398

Paid to pharmacies, not to this prescriber.

Other pain medicine in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →